0001144204-13-031661.txt : 20130524
0001144204-13-031661.hdr.sgml : 20130524
20130524202156
ACCESSION NUMBER: 0001144204-13-031661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130522
FILED AS OF DATE: 20130524
DATE AS OF CHANGE: 20130524
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QUILTY EDWARD J
CENTRAL INDEX KEY: 0001045507
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 13873228
MAIL ADDRESS:
STREET 1: DERMA SCIENCES, INC.
STREET 2: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
v346215_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2013-05-22
0
0000892160
DERMA SCIENCES, INC.
DSCI
0001045507
QUILTY EDWARD J
DERMA SCIENCES, INC.
214 CARNEGIE CENTER, SUITE 300
PRINCETON
NJ
08540
1
1
0
0
President & CEO
Stock Option (right to buy)
11.97
2013-05-22
4
A
0
24000
0
A
2013-05-22
2023-02-13
Common Stock
24000
24000
D
The option grant was approved by the compensation committee of the issuer's board of directors on February 13, 2013, subject to stockholder approval of an amendment to the issuer's equity incentive plan to increase the shares available for issuance thereunder. The issuer's stockholders approved the amendment on May 22, 2013.
The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date, subject to stockholder approval of the amendment to the issuer's equity incentive plan which was obtained on May 22, 2013, and will vest as to an additional 25% on February 13 of 2014, 2015 and 2016.
/s/ Edward J. Quilty
2013-05-24